MARIMED INC. 8-K

What Happened

• MariMed Inc. (MRMD) filed an 8‑K on June 8, 2026 reporting the results of its June 4, 2026 Annual Meeting of Stockholders. Stockholders re‑elected four directors—Jon R. Levine, Edward Gildea, David Allen and Eva Selhub, M.D.—to serve until the next annual meeting and, on an advisory basis, approved the appointment of M&K CPAs PLLC as the Company’s independent auditors for fiscal 2026.
• The proxy statement describing the matters was filed on Schedule 14A on April 23, 2026.

Key Details

• Election of directors vote totals:
  • Jon R. Levine — For: 111,339,122; Withheld: 14,355,396; Broker non‑vote: 119,765,107
  • Edward Gildea — For: 110,868,950; Withheld: 14,825,568; Broker non‑vote: 119,765,107
  • David Allen — For: 110,854,282; Withheld: 14,840,236; Broker non‑vote: 119,765,107
  • Eva Selhub, M.D. — For: 111,358,888; Withheld: 14,335,630; Broker non‑vote: 119,765,107
• Advisory approval of auditors:
  • M&K CPAs PLLC — For: 229,335,138; Against: 15,550,371; Abstain/Withheld: 574,116
• The 8‑K was signed by CFO Mario Pinho and reflects only the meeting results reported.

Why It Matters

• Re‑election of the four directors signals continuity of the current board for governance and strategy through the next annual meeting.
• The auditor appointment was advisory (non‑binding) but shows strong shareholder support for M&K CPAs PLLC for fiscal 2026.
• Material vote totals (including significant broker non‑votes) provide transparency on shareholder participation and support levels for these governance matters.